Mr. Thastrup
biotechnology
2cureX ApS
Denmark
Biography
Thastrup Co-founded 2cureX ApS in 2006 and serves as its Chief Executive Officer.
Research Interest
Mr. Thastrup served as Head of Carlsberg Biosector and was responsible for Carlsberg's biomedical research. He founded and served as Chief Technology Officer and Chief Scientific Officer of Fisher BioImage ApS that was spun-out of Novo Nordisk A/S as a drug discovery company fostering the novel discovery concept of Redistribution™. He has furthermore experience in managing drug discovery research units in the pharmaceutical and biotechnology industry (Novo Nordisk A/S and ZymoGenetics, Inc.). Mr. Thastrup serves as a Director of 2cureX ApS.
